CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 55.75 CNY | -0.48% |
|
-1.71% | -28.10% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Chengdu Kanghua Biological Products Co Ltd is a China-based company principally involved in the research and development, manufacturing and sales of vaccine products. The Company's main products are Rabies Vaccine (human diploid cell) for Human Use, Freeze-dried and Group ACYW135 Meningococcal Polysaccharide Vaccine. The Company distributes its products in domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
2024-04-22
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
55.75
CNY
Average target price
102
CNY
Spread / Average Target
+82.98%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -28.10% | 1.04B | |
| -5.99% | 84.46B | |
| +2.76% | 40.85B | |
| -24.88% | 27.69B | |
| +53.61% | 24.28B | |
| -8.08% | 17.09B | |
| -33.74% | 13.67B | |
| -16.63% | 11.86B | |
| -11.19% | 11.79B | |
| -2.25% | 8.07B |
- Stock Market
- Equities
- 300841 Stock
- News Chengdu Kanghua Biological Products Co., Ltd.
- Chengdu Kanghua Biological Products : to Unlock Restricted Shares
